Primary |
Computed Tomographic Colonography |
50.0% |
Sigmoidoscopy |
50.0% |
|
Electrolyte Imbalance |
50.0% |
Syncope |
50.0% |
|
Secondary |
Drug Use For Unknown Indication |
25.8% |
Shock |
15.2% |
Product Used For Unknown Indication |
10.6% |
Constipation |
7.1% |
Arrhythmia |
6.1% |
Colonoscopy |
5.1% |
Inflammation |
4.5% |
Dehydration |
3.0% |
Hypersensitivity |
3.0% |
Sedation |
3.0% |
Vitamin Supplementation |
2.5% |
Faeces Hard |
2.0% |
Acidosis |
1.5% |
Analgesic Effect |
1.5% |
Bowel Preparation |
1.5% |
Hyperglycaemia |
1.5% |
Hypermagnesaemia |
1.5% |
Insomnia |
1.5% |
Oesophageal Carcinoma |
1.5% |
Pneumonia Aspiration |
1.5% |
|
Vomiting |
25.0% |
Disorientation |
7.1% |
Flatulence |
7.1% |
Mallory-weiss Syndrome |
7.1% |
Mania |
7.1% |
Toxic Epidermal Necrolysis |
7.1% |
Diarrhoea |
3.6% |
Drug Ineffective |
3.6% |
Faecaloma |
3.6% |
Headache |
3.6% |
Renal Disorder |
3.6% |
Renal Haemorrhage |
3.6% |
Renal Tubular Necrosis |
3.6% |
Rhabdomyolysis |
3.6% |
Syncope |
3.6% |
Throat Irritation |
3.6% |
Weight Increased |
3.6% |
|
Concomitant |
Product Used For Unknown Indication |
24.6% |
Drug Use For Unknown Indication |
23.0% |
Constipation |
11.2% |
Pain |
6.9% |
Nausea |
4.8% |
Hypertension |
4.0% |
Prophylaxis |
3.2% |
Insomnia |
2.7% |
Multiple Myeloma |
2.1% |
Supplementation Therapy |
2.1% |
Osteoporosis |
2.0% |
Rheumatoid Arthritis |
1.8% |
Non-small Cell Lung Cancer |
1.7% |
Postoperative Care |
1.7% |
Anxiety |
1.6% |
Pancreatic Carcinoma |
1.4% |
Vitamin Supplementation |
1.4% |
Crohn's Disease |
1.3% |
Gastrooesophageal Reflux Disease |
1.3% |
Depression |
1.2% |
|
Vomiting |
12.4% |
Renal Failure Acute |
6.9% |
Syncope |
6.9% |
Weight Decreased |
6.9% |
Weight Increased |
6.2% |
Wheezing |
6.2% |
Pyrexia |
5.5% |
Urinary Tract Infection |
5.5% |
Constipation |
4.1% |
Nausea |
4.1% |
Pneumonia |
4.1% |
Small Intestinal Obstruction |
4.1% |
Transfusion |
4.1% |
Pain |
3.4% |
Sepsis |
3.4% |
Skin Infection |
3.4% |
Thrombocytopenia |
3.4% |
White Blood Cell Count Decreased |
3.4% |
Colitis Ulcerative |
2.8% |
Enterocolitis |
2.8% |
|